Madrigal Pharmaceuticals, Inc. Common Stock (MDGL) is a publicly traded Healthcare sector company. As of September 2, 2026, MDGL trades at $548.25 with a market cap of $12.48B and a P/E ratio of -47.77. MDGL moved +0.00% today. Year to date, MDGL is -9.29%; over the trailing twelve months it is +23.53%. Its 52-week range spans $265.00 to $615.00. Analyst consensus is strong buy with an average price target of $689.08. Rallies surfaces MDGL's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
13 analysts cover MDGL: 0 strong buy, 12 buy, 1 hold, 0 sell, and 0 strong sell. The consensus rating is strong buy. The average price target is $689.08.
| Metric | Value |
|---|---|
| Price | $548.25 |
| Market Cap | $12.48B |
| P/E Ratio | -47.77 |
| EPS | $-11.28 |
| Dividend Yield | 0.00% |
| 52-Week High | $615.00 |
| 52-Week Low | $265.00 |
| Volume | 7.28K |
| Avg Volume | 0 |
| Revenue (TTM) | $1.28B |
| Net Income | $-325.10M |
| Gross Margin | 0.00% |
13 analysts cover MDGL: 0 strong buy, 12 buy, 1 hold, 0 sell, 0 strong sell. Consensus rating is strong buy. Average price target: $689.08.